Chronomics CSO Daniel Herranz Interviews Dr. Seeds

About this video

In this 2020 interview, Chronomics CSO Daniel Herranz questions Seeds about peptide therapy and epigenetic testing. Seeds introduces peptides as endogenous signaling agents — amino-acid chains that can act as hormones, enzymes, ligands, or receptors — and claims they can help restore a cell’s metabolic flexibility and efficiency. The conversation centers on epigenetics: Seeds argues lifestyle stressors constantly reshape gene expression, that the epigenome is reversible, and that biological-age testing could let clinicians measure whether therapies are working. He cites early thymus-regeneration research involving growth hormone as proof of concept that biological age markers can move. He closes on healthspan — making the years a person’s genome allows more productive — rather than radical life extension.

Key takeaways

• Seeds presents peptides as precision signaling tools aimed at restoring cellular efficiency
• He argues epigenetic marks are reversible and measurable, making them a natural scorecard for therapy
• Seeds names nutrition and exercise as the body’s biggest positive peptide-producing influences
• He frames his aging goal as healthspan and function, not simply more years
• He sees personalized therapy plus objective molecular measurement as the future direction of preventive medicine

Episode details: published September 7, 2020 · 128 views · 26:31 long. Summary written by Self Growth Videos from the episode itself. The peptide and cellular-medicine concepts described are Dr. William Seeds’s, presented for education — not medical advice. Consult a qualified professional before changing your own health practices. Disclosure: the SSRP Institute sells clinician certification in peptide therapy.

← Previous: What Do Healthcare Professionals Think of Dr. Seeds? · Next: Peptide Therapy: Foundations | A Digital Course →

All Dr. William Seeds videos · Dr. William Seeds profile · SSRP Institute (official site)